Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amélie Marsot

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 23, 2020
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?Amélie Marsot
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 19, 2018
Pharmacokinetic Variability in Pediatrics and Intensive Care: Toward a Personalized Dosing ApproachAmélie Marsot
Clinical Pharmacology in Drug Development|March 11, 2024
Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic ModelsAlexandre Duong, Amélie Marsot
Clinical Pharmacokinetics|April 2, 2023
External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge GapsMehdi El Hassani, Amélie Marsot
Clinical Pharmacokinetics|December 4, 2025
Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision DosingMehdi El Hassani, Amélie Marsot
Clinical Pharmacokinetics|February 6, 2020
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In AdultsAbdullah Aljutayli, Amélie Marsot, Fahima Nekka
Clinical Pharmacokinetics|June 30, 2026
Population Pharmacokinetic Modelling of Dolutegravir: A Narrative ReviewÉmilie Pilote, Nancy L Sheehan, Amélie Marsot
British Journal of Clinical Pharmacology|December 4, 2024
A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonatesMehdi El Hassani, Mathieu Blouin, Amélie Marsot
European Journal of Drug Metabolism and Pharmacokinetics|May 5, 2024
Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?Mehdi El Hassani, Uwe Liebchen, Amélie Marsot
Therapeutic Drug Monitoring|February 12, 2025
External Evaluation of Longitudinal Population Pharmacokinetic Models of Vancomycin in Patients With Osteoarticular InfectionsVan Dong Nguyen, Alice Côté, Amélie Marsot
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 23, 2020
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?Amélie Marsot
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 19, 2018
Pharmacokinetic Variability in Pediatrics and Intensive Care: Toward a Personalized Dosing ApproachAmélie Marsot
Clinical Pharmacology in Drug Development|March 11, 2024
Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic ModelsAlexandre Duong, Amélie Marsot
Clinical Pharmacokinetics|April 2, 2023
External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge GapsMehdi El Hassani, Amélie Marsot
Clinical Pharmacokinetics|December 4, 2025
Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision DosingMehdi El Hassani, Amélie Marsot
Clinical Pharmacokinetics|February 6, 2020
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In AdultsAbdullah Aljutayli, Amélie Marsot, Fahima Nekka
Clinical Pharmacokinetics|June 30, 2026
Population Pharmacokinetic Modelling of Dolutegravir: A Narrative ReviewÉmilie Pilote, Nancy L Sheehan, Amélie Marsot
British Journal of Clinical Pharmacology|December 4, 2024
A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonatesMehdi El Hassani, Mathieu Blouin, Amélie Marsot
European Journal of Drug Metabolism and Pharmacokinetics|May 5, 2024
Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?Mehdi El Hassani, Uwe Liebchen, Amélie Marsot
Therapeutic Drug Monitoring|February 12, 2025
External Evaluation of Longitudinal Population Pharmacokinetic Models of Vancomycin in Patients With Osteoarticular InfectionsVan Dong Nguyen, Alice Côté, Amélie Marsot
Pageof 7